IL2 and neoplasm: Collectively, these results show that Ad5/3-E2F-D24-hTNFa-IRES-hIL-2 is capable of replicating in and lysing several types of human head and neck cancer, with subsequent release of TNFα and IL-2, despite histology or tumor location.